COVID-19 preclinical drug development database
Name: Giancarlo Biagini
Email Address: giancarlo.biagini@lstmed.ac.uk
Phone Number:
Key Collaborators:
1-3 months
Recent publications (albeit they are pre-prints and not yet peer reviewed): Therapeutics (pre-clinical drug discovery/pharmacology): NTZ dose prediction now on MedRxiv - https://www.medrxiv.org/content/10.1101/2020.05.01.20087130v1 Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection https://medrxiv.org/cgi/content/short/2020.04.24.20078741v1 Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics - https://www.medrxiv.org/content/10.1101/2020.04.16.20068379v1